Medline Inc(MDLN) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 7:56 PM ET (Korea 10/27 08:56)
Full metrics table
| Index | - | P/E | 39.51 | EPS (ttm) | 0.85 | Insider Own | 41.89% | Shs Outstand | 877.0M | Perf Week | -4.26% |
| Market Cap | 29.56B | Forward P/E | 21.6 | EPS next Y | 4.82% | Insider Trans | -26.36% | Shs Float | 509.8M | Perf Month | -2.91% |
| Enterprise Value | 47.02B | PEG | 2.82 | EPS next Q | 0.34 | Inst Own | 82.57% | Short Float | 10.33% | Perf Quarter | -16.84% |
| Income | 0.69B | P/S | 0.99 | EPS this Y | 4.01% | Inst Trans | 13.85% | Short Ratio | 6.61 | Perf Half Y | -25.51% |
| Sales | 29.94B | P/B | 2.55 | EPS next 5Y | 7.67% | ROA | 1.83% | Short Interest | 52.69M | Perf YTD | -19.79% |
| Book/sh | 13.19 | P/C | 11.03 | EPS past 3/5Y | - | ROE | 4.86% | 52W High | -33.78% ($50.88) | Perf Year | - |
| Cash/sh | 3.05 | P/FCF | 19.12 | Sales past 3/5Y | 9.85% - | ROIC | 2.87% | 52W Low | 6.99% ($31.49) | Perf 3Y | - |
| Dividend Est. | $0.04 (0.12%) | EV/EBITDA | 15.83 | EPS Y/Y TTM | -46.11% | Gross Margin | 23.85% | Volatility(W/M) | 3.16% 2.99% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 1.57 | Sales Y/Y TTM | 12.12% | Oper. Margin | 6.5% | ATR (14) | 1.14 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.61 | EPS Q/Q | -83.26% | Profit Margin | 2.31% | RSI (14) | 38.89 | Recom | 1.59 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.33 | Sales Q/Q | 11.6% | SMA20 | -4.77% ($35.38) | Beta | - | Target Price | $44.27 |
| Payout | - | Debt/Eq | 1.09 | Earnings | 2026/11/4 | SMA50 | -2.74% ($34.64) | Rel Volume | 1.02 | Prev Close | $34.09 |
| Employees | 45000 | LT Debt/Eq | 1.08 | EPS/Sales Surpr. | 41.88% 2.21% | SMA200 | -15.46% ($39.85) | Avg Volume(3M) | 7.97M | Price | $33.69 |
| IPO | 2025/12/17 | Option/Short | Yes/Yes | Trades | 39588 | Volume | 8,132,549 | Change | -1.17% |
A global healthcare supply chain company operating in medical supplies, devices, and medical distribution businesses. Founded in the United States in 1966 and headquartered in Northfield, Illinois, it broadly supplies hospitals, nursing homes, and outpatient clinics with medical consumables and its own branded products.
Over the past 1 year, on the lower side
34% below its 1-year high.
Traded about as much as usual. That is 102% of its average volume.
Next earnings report: November 4
8 days to go.
MDLN earns at a steady pace
Of every $100 in sales, $6.50 is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +4.0% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $2,160. Peers typically go for $1,968.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are roughly flat
Tap to view numbers
The dividend is on the small side
Pays 0.12% annually in dividends.
Tap to view numbers
Ownership is about average
Institutions hold 82.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #5 of 51 in the industry
Based on market cap of $30B.
FAQ
What kind of company is MDLN?
MDLN belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of MDLN?
The market cap of MDLN is approximately $29.6B, ranking 461 within its sector.
Does MDLN pay dividends?
MDLN has a dividend yield of approximately 0.12%, with an annual dividend of $0.04.
What is the P/E ratio of MDLN?
MDLN has a P/E ratio of approximately 39.5x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for MDLN?
MDLN has recorded a 52-week high of $50.88 and a low of $31.49.
